We have developed a viral RNA (vRNA) dot blot assay for identified a subset of candidate high-titer producer cell rapid identification of high-titer retrovirus vector production clones. In three independent screens the supernatant with by packaging cell clones. The procedure employs Trizol LS the highest biological titer was produced by one of the prereagent to purify vRNA from packaging cell supernatants, viously defined candidate high-titer producer clones. Our a sensitive dot blot assay, and PhosphorImager technology procedure greatly facilitates virus titration by: (1) rapidly elito quantify packaged viral genomes in 2 days. Experiments minating the vast majority of low-titer producer cell clones; performed on viral supernatants of known biological titer (2) accurately identifying the subset of candidate high-titer demonstrated that the vRNA dot blot assay was extremely producer clones for further biological titration and assesssensitive and that dot intensity correlated directly with viral ment of the proviral genomic structure; and (3) reducing titer. It is often necessary to analyze approximately 100 laborious tissue culture manipulations to a minimum. Furvirus producing cell clones, making this method useful as thermore, the reliance of this method on molecular deteca rapid screen to identify the highest virus producing tion makes it ideally suited for the isolation of high-titer clones. The vRNA dot blot assay consistently clones lacking a drug selection marker.
Introduction
indicator cell line and subsequent competitive PCR analyThe success of gene therapy and marking protocols that sis to quantify the number of proviral DNA genomes utilize retrovirus vectors is dependent on a source of present after 24 h. 4 This method is rapid, accurate and high-titer virus stocks.
1 These stocks are conventionally indicates that the virus has integrated. However, it does prepared by transfection of retrovirus vector DNA or by not avoid the need for assessing all of the candidate proinfection of transiently produced virus stocks into a packducer clones by infection of indicator cell lines. Although aging cell line.
2 However, only a small subset of packagthe above study concluded that viral RNA (vRNA) levels ing cell clones transduced in this manner actually prodid not correlate with observed biological titers, we have duce high titers of retrovirus. In order to identify these previously demonstrated that a rapid vRNA dot blot prorare high-titer producer clones, it is necessary to assess cedure could accurately identify high-titer production of the titer of dozens of producer cell lines. It is this step of retrovirus vectors lacking a selectable marker. 5 Moreover, virus production that is most laborious and time-consumwe utilized this procedure to identify high-titer proing as virus must be harvested from each producer cell ducers of nonselectable retrovirus vectors for use in gene line, used to infect an indicator cell line in several virus targeting experiments, 6 and for titrating an integrationdilutions, and the biological titer determined after up to defective retrovirus vector that was used to study the 2 weeks of drug exposure to select the marker gene mechanism of retrovirus integration. 7 included in the virus. In the meantime, each producer However, this method was cumbersome. In brief, RNA cell clone must be maintained or frozen. In addition, this was extracted from 2 ml of virus stock and precipitated approach is not suitable for retrovirus vectors that lack a overnight, transferred on to nitrocellulose filters in a dot selectable marker gene, which often express higher levels blot apparatus, hybridized overnight with an RNA probe of virus than those containing multiple genes, and these made using SP6 polymerase, and the washed filter vectors are commonly titrated by performing Southern exposed overnight to autoradiographic film. Here, we blots on infected indicator cells. 3 have refined the vRNA dot blot assay using commercially Alternative methods for rapid titration of retrovirus available reagents to extract 300 l of virus stock in stocks that lack selectable marker genes have been Eppendorf tubes, dot blot the RNA on to filters and hybridize with random primed DNA probes in a single day. The next day, filters are washed and exposed for 4 h on to PhosphorImager screens to visualize the blot. The producer clones in 2 days. Only the best candidate prosample ( Figure 2a , lanes 1 and 2). To determine the reproducibility of the extraction, viral supernatant from ducer cell clones need be maintained or frozen, and only these are subjected to conventional biological titer assays the PG13LNc8 cell line was collected and four 300 l aliquots were simultaneously extracted and blotted on to and Southern blot analyses of infected indicator cells. In this manner, the clone that produces the highest titer of the membrane (lane 5). The relatively equal intensities of these signals confirmed the reproducibility of the extraccorrectly integrated provirus is rapidly defined while laborious tissue culture procedures are kept to a tion procedure. Hybridization signal intensities were shown to correlate with the amount of vRNA blotted by minimum.
diluting the amount of sample loaded starting at 1:1, which represents the amount of vRNA extracted from a
Results viral supernatant volume of 300 l, and making 1:2 serial dilutions to a 1:8 dilution of the original sample (lanes 3 and 4). The intensity of individual hybridization signals Sensitivity and quantification of viral RNA dot blot assay We previously demonstrated that vRNA dot blots are an was analyzed in lanes 3 and 4 and the percentage of these signals was plotted against the vRNA dilution (Figure accurate method to titrate retrovirus vectors, but the protocol was cumbersome. 5 The introduction of Trizol LS 2b). This analysis determined that when the viral supernatant was diluted on to the membrane, the assay was reagent for extraction of RNA present in liquids suggested that vRNA could be extracted more rapidly, and quantitative and the relationship was linear. Biological titers were determined using standard protocols 13 for the the sensitivity of PhosphorImager screens indicated that smaller amounts of vRNA could be detected with shorter samples shown in lanes 3 and 4, using two to three plates of Hela cells at dilutions ranging from 10 −3 to 10
. The exposure times. By combining these refinements with improved filter membranes, such as Hybond-N, and the titer correlated with the hybridization signal intensities. PA317MSCV (lane 3, titer of 1.5 × 10 5 c.f.u./ml) had a ease of preparing random-primed DNA probes using kits, it was evident that the vRNA dot blot assay could more intense hybridization signal than PG13LNc8 (lane 4, titer of 3.1 × 10 4 c.f.u./ml). be significantly improved.
In order to determine whether this assay could be used To determine the effect of cell density, the vRNA assay was performed on supernatants obtained from retroviral to detect vRNA extracted using Trizol LS, we used two different virus producing cell lines, PA317MSCV
8 and producing cells plated with a range of cell doses from 10 6 to 3.5 × 10 6 cells per T25 cm 2 flask. The optimal cell dose PG13LNc8.
9 Each cell line produces retrovirus containing the neo gene from the transposon Tn5. 10 The cell lines was 3 × 10 6 cells, plating at 3.5 × 10 6 resulted in detachment of the cells and a decrease in pH. were seeded into T25 cm 2 flasks having 3 × 10 6 cells in 5 ml of media. The flasks were left until the next day before harvesting of the supernatant for vRNA extraction and subsequent blotting on to membranes (outlined in Figure  Isolation of high-titer PG13 clones producing MSCV virus 1 legend). Figure 2a shows that hybridization with a neo probe is effective for detecting the extracted vRNA (lanes We next determined whether this assay was able to distinguish those clones producing a high retroviral titer 1-5). In an attempt to improve both the quantity and quality of the vRNA and to ensure that there was no from those having a lower, inefficient titer. We used the PA317MSCV producer cell line to infect the PG13 pack-RNA contamination from the virus producing cells, vRNA was extracted from untreated viral supernatant, aging cell line, using standard protocols, 13 isolated 24 G418-resistant clones and approximately 24 h after platfiltered supernatant, and from supernatant spun at 300 g for 10 min. The intensity of the hybridization signals ing 3 × 10 6 virus producing cells per T25 cm 2 flask, subjected them to biological titrating on Hela cells with simproved to be similar regardless of the viral supernatant treatment before extraction (data not shown). To ensure ultaneous extraction of their vRNA (Figure 3a and b). vRNA samples from each clone were diluted and blotted, that the hybridization signals seen with these cell lines were specific for neo retroviral sequences, vRNA was starting at 1:1, which represents the amount of vRNA extracted from 300 l of viral supernatant, making serial extracted from PG13 9 and PA317 11 packaging cell lines lacking any neo sequences, and blotted with no resulting dilutions of 1:2 and 1:4 of the original sample, with a PG13LNc8 control. The biological titers varied, ranging hybridization signals (lanes 6 and 7). To ensure further that the hybridization signal was specific for neo retrovifrom 1-5 × 10 3 c.f.u./ml (Nos 17 and 24, respectively) to 2-5 × 10 5 c.f.u./ml, with No. 15 being the highest aside ral sequences, vRNA was extracted from a retrovirus producing cell line lacking the neo gene and known to be of from the PG13LNc8-positive control which was 6.6 × 10 5 c.f.u./ml. We determined the hybridization signal intenhigh titer, PG13HYTK.
12 PG13HYTK contains the drug selection marker for hygromycin B resistance and did not sities using the three hybridization signals for each clone. The signal intensity was calculated per microliter of repproduce a hybridization signal when probed with neo (lane 8). resentative viral supernatant loaded, then plotted against the biological titer, which was averaged from the titer of To establish whether the vRNA extraction was quantitative, we extracted vRNA from PA317MSCV and two to four plates at dilutions ranging from 10 −3 to 10 . As illustrated by Figure 3b , the clones having the most PG13LNc8 starting with 300 l of viral supernatant and from a 1:3 diluted sample (eg a total volume of 300 l intense hybridization signals were also those with the highest titers. Therefore, there would be no exclusion of composed of 100 l of viral supernatant with the addition of 200 l of media). A comparison of the intensities of high-titer clones if the dot blot alone were used for this determination. This Figure also shows that there is a linthe hybridization signals for both cell lines showed that vRNA extracted from 300 l of viral supernatant was ear relationship between the hybridization signal intensity for these clones and their biological titer (R 2 = 0.84). approximately three times stronger than the diluted Rapid screen for high-titer producer cell clones humans. The respective cDNAs were inserted into the MSCV retroviral vector. Both vectors were transfected To determine whether this screening technique would be useful for isolating high-titer clones from other virus prointo PA317 cells and 24 h later transient viral supernatants were used to infect PG13 packaging cells. 13 PG13 ducing cell lines and to determine whether a single dot representing 300 l of viral supernatant would be sufproducer clones were isolated after G418 selection. In an attempt to reduce the time and labor involved in isolating ficient for this isolation when the cells were estimated to be confluent, we screened two novel retrovirus vectors. viral supernatants we omitted the step of counting and seeding 3 × 10 6 virus producing cells and instead viral AML-EVI 14 is a fusion gene formed by the translocation of the Evi-1 gene on chromosome 3 with the AML1 gene supernatants were sampled after the cultures were estimated to be confluent and their titers determined on Hela on chromosome 21, while TLS-ERG 14 is a fusion gene formed by the translocation of the ERG gene on chromocells from a single plate at a dilution of 10 −3 . After screening 21 clones from PG13AML-EVI (only 15 are shown), some 21 with the TLS/FUS gene on chromosome 16 in 12/21 had titers of less than 10 3 c.f.u./ml (ie showing no clones showed a linear relationship between their hybridization signal intensities and their biological titers (R 2 = 0.73). For the PG13TLS-ERG clones, 33 were analyzed by vRNA dot blot, of which six seemed to be candidates for cell lines, the PG13TLS-ERG clones did not display a linear relationship between their hybridization signal intenhigh-titer clones Nos 4, 6, 8, 9, 27 and 30 on the basis of their hybridization signal intensities (Figure 4c ). In this sities and their biological titers. These data agree with our earlier finding that a single dot of undiluted vRNA group, Nos 27 and 30 were seen to have the highest titers, 1.2 × 10 5 c.f.u./ml and 1.3 × 10 5 c.f.u./ml, respectively, gives more variable results and that the most accurate titers are determined from serial RNA dilutions. 5 Neverwhile Nos 4, 6 and 8 had titers ranging from 1.2 × 10 4 to 5.3 × 10 4 c.f.u./ml. Clone No. 9 was unique in the fact theless, the dot blot of undiluted vRNA still identified two of the three best producer clones including the cell that it gave no G418 resistant colonies on Hela cells even though it displayed an intense hybridization signal.
clone (No. 30) with the highest biological titer. Clone No. 2 displayed a moderate hybridization signal and as such would not have been selected for further Discussion investigation, although its biological titer was 1.2 × 10 5 vRNA dot blot assays are rapid, simple and sensitive c.f.u./ml. Unlike previously screened virus producing techniques to isolate quantitatively high-titer retroviral producing cell lines. vRNA is extracted from cell supernatants, blotted on to a membrane and hybridized with radiolabeled probes. Our previously described protocol was slower, used larger viral volumes, required the use of many RNase free solutions, and used RNA probes that required subcloning. 5 Here, we have refined all aspects of the vRNA dot blot assay by using: (1) Trizol LS reagent to rapidly extract 300 l of virus stock in Eppendorf tubes and to reduce the previous RNA precipitation step to just 10 min; (2) Hybond-N membranes and PhosphorImager screens to provide stronger signals resulting in higher sensitivities and shorter exposure times; and (3) radiolabeled random-primed probes made from gel purified DNA templates to avoid the use of RNA probes.
Our preliminary experiments demonstrated that vRNA was easily detectable using the refinements described above, and we subsequently titrated 78 packaging cell clones producing three different vectors (summarized in Table 1 ). In addition to the vectors described in detail here, we have used this candidate approach to screen 95 clones producing purine nucleoside phosphorylase 15 (PNP) MSCV-based vectors and in each case succeeded in rapidly identifying the highest titer clones (see Table  1 ). The best titer of the nonselectable PNP vector producer clones assayed by comparative Southern blots on infected Rat 2 cells is approximately 1 × 10 5 (data not shown), a value that is similar to those of the selectable vectors. These data show that we rapidly reduced a total of 173 producer clones to a subset of 31 candidate high- Figure 4b . 
